Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party

Mariasanta Napolitano, Laura Candiotto, Marco Basso, Cristina Tassinari, Sergio Storti, Dino Veneri, Giuseppe Tagariello, Giancarlo Castaman, Valerio De Stefano, Anna Falanga, Augusto B. Federici, Rita Santoro

Risultato della ricerca: Article

4 Citazioni (Scopus)

Abstract

Following high-dose chemotherapy/bone marrow transplantation, patients are routinely, prophylactically transfused with platelet concentrates (PC) if they have a platelet count 10×10(9)/L or higher in the presence of risk factors for bleeding. However, whether such transfusions are necessary in clinically stable patients with no bleeding, or whether a therapeutic transfusion strategy could be sufficient and safe, is still debated.
Lingua originaleEnglish
pagine (da-a)1-6-
Numero di pagine6
RivistaBlood Transfusion
Stato di pubblicazionePublished - 2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Hematology

Cita questo

Napolitano, M., Candiotto, L., Basso, M., Tassinari, C., Storti, S., Veneri, D., Tagariello, G., Castaman, G., De Stefano, V., Falanga, A., Federici, A. B., & Santoro, R. (2016). Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. Blood Transfusion, 1-6-.